PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-61.23%
Negative net income growth while TSM stands at 12.43%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
5.33%
Some D&A expansion while TSM is negative at -36.92%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-100.52%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
-85.09%
Negative yoy working capital usage while TSM is 68.45%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
67.16%
AR growth of 67.16% while TSM is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-134.57%
Negative yoy inventory while TSM is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
289.53%
AP growth of 289.53% while TSM is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-112.19%
Negative yoy usage while TSM is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
348.40%
Well above TSM's 3.66%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-67.48%
Both yoy CFO lines are negative, with TSM at -19.40%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-157.46%
Negative yoy CapEx while TSM is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-100.00%
Negative yoy acquisition while TSM stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-14.69%
Both yoy lines negative, with TSM at -261.02%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
23.49%
We have some liquidation growth while TSM is negative at -100.00%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
100.00%
Growth well above TSM's 99.07%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-15.66%
Both yoy lines negative, with TSM at -47.46%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
700.61%
Issuance growth of 700.61% while TSM is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.